Evidence that the risks of misoprostol outweigh its benefits in stable cyclosporine-treated renal allograft recipients.
Wilkie
M E
ME
Department of Nephrology, Royal London Hospital, London Hospital Medical College, Whitechapel, United Kingdom.
Beer
J C
JC
Newman
D
D
Raftery
M J
MJ
Marsh
F P
FP
D000328:Adult; D000368:Aged; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016595:Misoprostol / Q000009:adverse effects*; D012307:Risk Factors; D014184:Transplantation, Homologous
D016595:Misoprostol; D016572:Cyclosporine